This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1076029607304721v1 1076029607304721v2    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Shelat, S. G. Articles by Pollak, E. S. Search for Related Content PubMed PubMed Citation Articles by Shelat, S. G. Articles by Pollak, E. S. Social Bookmarking                   What's this?

Serologic Results in >1000 Patients With Suspected Heparin-Induced Thrombocytopenia

¹ Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
² Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
³ Hospital of the University of Pennsylvania and the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

^* To whom correspondence should be addressed. E-mail: suresh{at}alum.mit.edu.

	Abstract

Heparin-induced thrombocytopenia (HIT) can lead to life-threatening and limb-threatening thrombosis. HIT is thought to be initiated by the interaction of pathogenic antibodies toward a complex platelet factor 4 (PF4) and heparin (PF4:H), which can activate platelets and predispose to thrombosis. As such, the laboratory diagnosis of HIT includes antigenic and functional assays to detect antibodies directed at PF4:H complexes. We performed a retrospective analysis of 1017 consecutive samples tested by serotonin-release assay and by enzyme-linked immunosorbent assay (ELISA). Most samples showed no serologic evidence of HIT, whereas 4% to 5% of samples demonstrated both antigenic and functional serological evidence for HIT. Approximately 12% to 18% of samples showed immunologic evidence of anti-PF4:H antibodies but without functional evidence of serotonin release in vitro. Interestingly, a small minority of samples (0.7%) caused serotonin release but were negative in the ELISA. The results are presented using cutoff values established at our hospital and for the ELISA manufacturer. This study provides a pretest probability of the serologic results from an antigenic assay (ELISA) and a functional assay (serotonin-release assay) in patients clinically suspected of having HIT.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?